Skip to main content
. 2018 May;10(5):2948–2959. doi: 10.21037/jtd.2018.05.55

Figure 1.

Figure 1

Research roadmap. NSCLC, non-small cell lung cancer; ALK, anaplastic lymphoma kinase; ROS1, c-ros oncogene 1; TP53, tumor protein 53; PFS, progression-free survival; NGS, next generation sequencing; AF, allelic fraction; ACMs, additional coexisting mutations.